Literature DB >> 20486820

COPD recent findings: impact on clinical practice.

Annabelle Couillard1, Jean François Muir, Daniel Veale.   

Abstract

Chronic obstructive pulmonary disease is now considered as a systemic disease originating in the lungs. The natural history of this disease reveals numerous extrapulmonary manifestations and co-morbidity factors that complicate the evolution of COPD. Recent publications have documented these systemic manifestations and co-morbidities and clarified somewhat the role of muscle dysfunction, nutritional anomalies, endocrine dysfunction, anaemia, osteoporosis and cardiovascular and metabolic disorders as well as lung cancer and psychological elements in this complex disease. Importantly, recent studies have shown that effort intolerance, exertional desaturation, loss of autonomy and reduced physical activity, loss of muscle mass and quadriceps strength as well as dyspnoea and impaired quality of life can be considered as independent predictive factors for survival in COPD. Use of these data may advance understanding of mechanisms; improve evaluation and thereby patient management in COPD.

Entities:  

Mesh:

Year:  2010        PMID: 20486820     DOI: 10.3109/15412555.2010.482115

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  3 in total

1.  Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients.

Authors:  Tadeusz Pietras; Janusz Szemraj; Michał Panek; Andrzej Witusik; Maciej Banasiak; Adam Antczak; Paweł Górski
Journal:  Mol Biol Rep       Date:  2011-06-08       Impact factor: 2.316

Review 2.  Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer.

Authors:  Derek Grose; Robert Milroy
Journal:  J Comorb       Date:  2011-12-27

3.  Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study.

Authors:  Swati Gulati; J Michael Wells; Gisel P Urdaneta; Kira Balestrini; Isabel Vital; Katherine Tovar; Jarrod W Barnes; Surya P Bhatt; Michael Campos; Stefanie Krick
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.